4//SEC Filing
SCICLONE PHARMACEUTICALS INC 4
Accession 0000880771-16-000212
CIK 0000880771operating
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:25 PM ET
Size
10.1 KB
Accession
0000880771-16-000212
Insider Transaction Report
Form 4
Chern Carey
General Counsel
Transactions
- Award
Incentive Stock Option (right to buy)
2016-11-14+38,644→ 38,644 totalExercise: $10.35Exp: 2026-11-14→ Common Stock (38,644 underlying) - Award
Non-Qualified Stock Option (right to buy)
2016-11-14+41,356→ 41,356 totalExercise: $10.35Exp: 2026-11-14→ Common Stock (41,356 underlying) - Award
Restricted Stock Unit
2016-11-14+30,000→ 30,000 totalExercise: $0.00→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]25% of such shares vest on October 24, 2017 and 2.0833% vests each month thereafter provided that the Reporting Person continues to be employed by the Issuer.
- [F3]Vesting for such RSUs will occur 25% on October 24, 2017, 25% on October 24, 2018, 25% on October 24, 2019, and 25% on October 24, 2020, or, in the discretion of the Company, such later date on which the sale of the Stock to be issued in settlement of such Unit would not violate the Trading Compliance Policy.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000880771
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 4:25 PM ET
- Size
- 10.1 KB